Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program

References

• Baldani DP, Skrgatic L, Ougouag R. Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women. Int J Endocrinol. 2015;2015:786362. doi:10.1155/2015/786362
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet (London, England). 2007;370(9588):685–697. doi:10.1016/S0140-6736(07)61345-2
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364–379. doi:10.1016/j.fertnstert.2018.05.004
   PubMed Web of Science ®Google Scholar
• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13. doi:10.2147/CLEP.S37559
   PubMed Web of Science ®Google Scholar
• Pfieffer ML. Polycystic ovary syndrome: diagnosis and management. Clin Med Res. 2019;44:30–35.
   Google Scholar
• Ali AT. Polycystic ovary syndrome and metabolic syndrome. Ceska Gynekol. 2015;80(4):279–289.
   PubMedGoogle Scholar
• Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91(3):781–785. doi:10.1210/jc.2005-2153
   PubMed Web of Science ®Google Scholar
• Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006;91(3):786–789. doi:10.1210/jc.2005-2501
   Web of Science ®Google Scholar
• Skiba MA, Islam RM, Bell RJ, Davis SR. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018;24(6):694–709. doi:10.1093/humupd/dmy022
   PubMed Web of Science ®Google Scholar
• Guraya SS. Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females. J Microsc Ultrastruct. 2013;1:30–34. doi:10.1016/j.jmau.2013.06.002
   Google Scholar
• Al Bassam NM, Ali S, Rahman SR. Polycystic ovarian syndrome (PCOS), awareness among female students, qassim university, Qassim Region, Saudi Arabia. Int J Res Granthaalayah. 2018;6:395–406.
   Google Scholar
• Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 2011;62(3):238–242.
   Web of Science ®Google Scholar
• Ding T, Hardiman PJ, Petersen I, et al. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351–96358. doi:10.18632/oncotarget.19180
   PubMedGoogle Scholar
• Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the short form-36 (SF-36). Gynecol Endocrinol. 2006;22(2):80–86. doi:10.1080/09513590600604541
   PubMed Web of Science ®Google Scholar
• Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279–2286. doi:10.1093/humrep/dem108
   PubMed Web of Science ®Google Scholar
• Li Y, Li Y, Yu Ng EH, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril. 2011;96(2):452–458. doi:10.1016/j.fertnstert.2011.05.072
   PubMed Web of Science ®Google Scholar
• Deeks AA, Gibson-Helm ME, Paul E, Teede HJ. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011;26(6):1399–1407. doi:10.1093/humrep/der071
   PubMed Web of Science ®Google Scholar
• Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83. doi:10.1007/s11920-017-0834-2
   PubMed Web of Science ®Google Scholar
• Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018;40(3):239–246. doi:10.4103/IJPSYM.IJPSYM_561_17
   PubMedGoogle Scholar
• Farkas J, Rigo A, Demetrovics Z. Psychological aspects of the polycystic ovary syndrome. Gynecol Endocrinol. 2014;30(2):95–99. doi:10.3109/09513590.2013.852530
   PubMed Web of Science ®Google Scholar
• Hung J-H, Hu L-Y, Tsai S-J, et al. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One. 2014;9(5):e97041. doi:10.1371/journal.pone.0097041
   PubMed Web of Science ®Google Scholar
• Watson K, Nasca C, Aasly L, McEwen B, Rasgon N. Insulin resistance, an unmasked culprit in depressive disorders: promises for interventions. Neuropharmacol. 2018;136:327–334. doi:10.1016/j.neuropharm.2017.11.038
   PubMed Web of Science ®Google Scholar
• Sartorius N. Depression and diabetes. Dialogues Clin Neurosci. 2018;20(1):47–52.
   PubMed Web of Science ®Google Scholar
• Mathur R, Levin O, Azziz R. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag. 2008;4:487–492. doi:10.2147/TCRM.S6864
   PubMedGoogle Scholar
• Wang R, Kim BV, Van Wely M, et al. Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. bmj. 2017;356:j138.
   PubMed Web of Science ®Google Scholar
• Abu Hashim H, Foda O, Ghayaty E. Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2015;94(9):921–930. doi:10.1111/aogs.12673
   Web of Science ®Google Scholar
• Palomba S, Falbo A, Zullo F, Orio JF. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30(1):1–50.
   PubMed Web of Science ®Google Scholar
• Fux Otta C, Wior M, Iraci GS, et al. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Gynecol Endocrinol. 2010;26(3):173–178. doi:10.3109/09513590903215581
   PubMed Web of Science ®Google Scholar
• Macut D, Bjekic-Macut J, Rahelic D, Doknic M. Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract. 2017;130:163–170. doi:10.1016/j.diabres.2017.06.011
   PubMed Web of Science ®Google Scholar
• Kurzthaler D, Hadziomerovic-Pekic D, Wildt L, Seeber BE. Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects. Reprod Biol Endocrinol. 2014;12(1):98. doi:10.1186/1477-7827-12-98
   Web of Science ®Google Scholar
• Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577–1585. doi:10.1007/s00125-017-4342-z
   PubMed Web of Science ®Google Scholar
• Castro Cabezas M, van Wijk JP, Elte JW, Klop B. Effects of metformin on the regulation of free fatty acids in insulin resistance: a double-blind, placebo-controlled study. J Nutr Metab. 2012;2012:394623. doi:10.1155/2012/394623
   Google Scholar
• Kashani L, Omidvar T, Farazmand B, et al. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology. 2013;38(6):767–776. doi:10.1016/j.psyneuen.2012.08.010
   PubMed Web of Science ®Google Scholar
• Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics. 2001;107(4):E55. doi:10.1542/peds.107.4.e55
   Web of Science ®Google Scholar
• Guo M, Mi J, Jiang QM, et al. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharmacol Physiol. 2014;41(9):650–656.
   PubMed Web of Science ®Google Scholar
• Shivavedi N, Kumar M, Tej G, Nayak PK. Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats. Brain Res. 2017;1674:1–9. doi:10.1016/j.brainres.2017.08.019
   PubMed Web of Science ®Google Scholar
• Khedr SA, Elmelgy AA, El-Kharashi OA, et al. Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-jun repression. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(4):407–422. doi:10.1007/s00210-018-1466-8
   PubMed Web of Science ®Google Scholar
• Hahn S, Benson S, Elsenbruch S, et al. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod. 2006;21(7):1925–1934. doi:10.1093/humrep/del069
   Web of Science ®Google Scholar
• Moll E, van Wely M, Lambalk CB, Bossuyt PM, van der Veen F. Health-related quality of life in women with newly diagnosed polycystic ovary syndrome randomized between clomifene citrate plus metformin or clomifene citrate plus placebo. Hum Reprod. 2012;27(11):3273–3278. doi:10.1093/humrep/des310
   Web of Science ®Google Scholar
• Sirota I, Stein DE, Vega M, Keltz MD. Insulin Resistance and β-cell Function Calculated by Homeostasis Model Assessment in Lean, Overweight, and Obese Women with Polycystic Ovary Syndrome. J Reprod Med. 2016;61:3–10.
   Google Scholar
• Louwers Y, Lao O, Fauser BC, Kayser M, Laven JS. The impact of self-reported ethnicity versus genetic ancestry on phenotypic characteristics of polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 2014;99(10):E2107–E2116.
   PubMed Web of Science ®Google Scholar
• Huang Z, Yong EL. Ethnic differences: is there an Asian phenotype for polycystic ovarian syndrome? Best Pract Res Clin Obstet Gynaecol. 2016;37:46–55. doi:10.1016/j.bpobgyn.2016.04.001
   PubMed Web of Science ®Google Scholar
• Wang R, Mol BWJ. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Hum Reprod. 2017;32(2):261–264. doi:10.1093/humrep/dew287
   Web of Science ®Google Scholar
• Carlson RV, Boyd KM, Webb DJ. The revision of the declaration of Helsinki: past, present and future. Br J Clin Pharmacol. 2004;57(6):695–713. doi:10.1111/j.1365-2125.2004.02103.x
   PubMed Web of Science ®Google Scholar
• Lenze EJ, Sheffrin M, Driscoll HC, et al. Incomplete response in late-life depression: getting to remission. Dialogues Clin Neurosci. 2008;10(4):419–430.
   PubMedGoogle Scholar
• AlHadi AN, AlAteeq DA, Al-Sharif E, et al. An arabic translation, reliability, and validation of patient health questionnaire in a Saudi sample. Ann Gen Psychiatry. 2017;16(1):32. doi:10.1186/s12991-017-0155-1
   PubMed Web of Science ®Google Scholar
• Sawaya H, Atoui M, Hamadeh A, Zeinoun P, Nahas Z. Adaptation and initial validation of the patient health questionnaire - 9 (PHQ-9) and the generalized anxiety disorder - 7 questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Res. 2016;239:245–252. doi:10.1016/j.psychres.2016.03.030
   PubMed Web of Science ®Google Scholar
• Coons SJ, Alabdulmohsin SA, Draugalis JR, Hays RD. Reliability of an Arabic version of the RAND-36 health survey and its equivalence to the US-English version. Med Care. 1998;36(3):428–432. doi:10.1097/00005650-199803000-00018
   PubMed Web of Science ®Google Scholar
• Al-Jumaili AA, Al-Rekabi MD, Sorofman B. Evaluation of instruments to assess health literacy in Arabic language among Iraqis. Res Social Adm Pharm. 2015;11(6):803–813. doi:10.1016/j.sapharm.2015.02.002
   PubMed Web of Science ®Google Scholar
• Morris NS, MacLean CD, Chew LD, Littenberg B. The single item literacy screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract. 2006;7(1):21. doi:10.1186/1471-2296-7-21
   PubMedGoogle Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325. doi:10.7326/0003-4819-146-5-200703060-00004
   PubMed Web of Science ®Google Scholar
• Wang CP, Lorenzo C, Habib SL, Jo B, Espinoza SE. Differential effects of metformin on age related comorbidities in older men with type 2 diabetes. J Diabetes Complications. 2017;31(4):679–686. doi:10.1016/j.jdiacomp.2017.01.013
   PubMed Web of Science ®Google Scholar
• Aswar U, Chepurwar S, Shintre S, Aswar M. Telmisartan attenuates diabetes induced depression in rats. Pharmacol Rep PR. 2017;69(2):358–364. doi:10.1016/j.pharep.2016.12.004
   PubMed Web of Science ®Google Scholar
• Moulton CD, Hopkins CWP, Ismail K, Stahl D. Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials. Psychoneuroendocrinology. 2018;94:91–103. doi:10.1016/j.psyneuen.2018.05.010
   PubMed Web of Science ®Google Scholar
• Tu HP, Lin C-H, Hsieh H-M, et al. Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000–2010. Psychiatr Q. 2017;88(1):75–91. doi:10.1007/s11126-016-9436-0
   Web of Science ®Google Scholar
• Reddy BR, Maitra S, Jhelum P, et al. Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats. J Biosci. 2016;41(3):407–417. doi:10.1007/s12038-016-9627-8
   Web of Science ®Google Scholar
• Erensoy H, Niafar M, Ghafarzadeh S, Aghamohammadzadeh N, Nader ND. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(1):72–75. doi:10.1080/09513590.2018.1498476
   PubMed Web of Science ®Google Scholar
• Benson S, Arck PC, Tan S, et al. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2009;34(5):727–735. doi:10.1016/j.psyneuen.2008.12.001
   PubMed Web of Science ®Google Scholar
• Kawamura S, Maesawa C, Nakamura K, et al. Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population. Neuropsychiatr Dis Treat. 2011;7:655–662. doi:10.2147/NDT.S25504
   Web of Science ®Google Scholar
• Cesta CE, Kuja-Halkola R, Lehto K, Iliadou AN, Landen M. Polycystic ovary syndrome, personality, and depression: A twin study. Psychoneuroendocrinology. 2017;85:63–68. doi:10.1016/j.psyneuen.2017.08.007
   Web of Science ®Google Scholar
• Day F, Karaderi T, Jones MR, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018;14(12):e1007813. doi:10.1371/journal.pgen.1007813
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Yee SW, Giacomini KM. Pharmacogenetics of antidiabetic drugs. Adv Pharmacol. 2018;83:361–389. doi:10.1016/bs.apha.2018.04.005
   PubMedGoogle Scholar
• Song DK, Hong YS, Sung YA, Lee H. Insulin resistance according to beta-cell function in women with polycystic ovary syndrome and normal glucose tolerance. PLoS One. 2017;12(5):e0178120. doi:10.1371/journal.pone.0178120
   PubMed Web of Science ®Google Scholar
• Glintborg D, Mumm H, Hougaard D, Ravn P, Andersen M. Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clin Endocrinol (Oxf). 2010;73(6):732–738. doi:10.1111/j.1365-2265.2010.03873.x
   PubMed Web of Science ®Google Scholar
• Welt CK, Arason G, Gudmundsson JA, et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab. 2006;91(11):4361–4368. doi:10.1210/jc.2006-1191
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu B, Yang Y, et al. Metformin exerts antidepressant effects by regulated DNA hydroxymethylation. Epigenomics. 2019;11(6):655–667. doi:10.2217/epi-2018-0187
   Web of Science ®Google Scholar
• Keshavarzi S, Kermanshahi S, Karami L, et al. Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: the role of CREB/BDNF and Akt/GSK3 signaling pathways. Neurotoxicol. 2019;72:74–84. doi:10.1016/j.neuro.2019.02.004
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoS Med. 2008;5(3):e67. doi:10.1371/journal.pmed.0050067
   PubMed Web of Science ®Google Scholar